Skip to content

Fatty liver is common, silent, and treatable when found early.

Clear, trusted education on MASLD and MASH in Arabic and English, for patients, families, and the doctors who care for them.

I'm a patient Patient Portal, for patients and families: plain guides, 28 questions answered, and a risk check. I'm a doctor Physician Portal, for healthcare professionals: a reference library, FIB-4 and NFS calculators, and learning by role.

Over years, fatty liver can scar the liver. Doctors grade this scarring (fibrosis) in five stages:

F0No scarring

F1Mild

F2Moderate

F3Advanced

F4Cirrhosis

Best time to find it and act At these stages, scarring can often improve.

Needs a liver specialist

Am I at risk?

Five quick yes-or-no questions. Nothing you answer is saved.

My liver journey

What happens from the first blood test to long-term follow-up.

FIB-4 for clinicians

The first step of the fibrosis pathway, with guideline cut-offs.

Fatty liver at a glance

From a normal liver to fat build-up (MASLD), inflammation (MASH) and the five stages of scarring (F0 to F4).

Illustration: a normal liver; a yellow fatty liver (MASLD, fat build-up); an inflamed fatty liver (MASH: fat, inflammation and liver cell injury), which is a form of MASLD. Below, five livers show fibrosis stages F0 no scarring, F1 mild, F2 moderate, F3 advanced and F4 cirrhosis, where the liver surface is lumpy. — Illustration only: a liver's appearance does not make a diagnosis. Read what MASH is and how fibrosis risk is checked.

Explore the academy

28Patient answersPlain questions and answers 4Printable guidesPlate, shopping, walking, Ramadan 10Calculators for cliniciansFIB-4, Agile, FAST and more 5Teaching modulesChapters with cases and quizzes 15Reference topicsThe doctors' library Publication RadarNew papers every day

Upcoming expert sessions

Meet the Expert

Upcoming events

All news and events

Latest news

Patient talks in Arabic

About the Academy

The Metabolic Liver Academy is an independent, bilingual education academy for fatty liver disease. Everything we publish is free, follows international and Saudi guidelines, lists its sources, and carries a public review record.

Founded and directed by Dr. Mahmoud Al-Desoky, Consultant Internist and Gastroenterologist
Open to specialist reviewers and faculty from across the region
No sponsors, no advertising, no tracking

Our mission and people · How we review content

Why our region

39%

of people in the Middle East and North Africa have fatty liver

69%

of people with type 2 diabetes in the region

See the evidence →

Stay in touch

New patient guides, expert interviews and events, about once a month. No advertising; unsubscribe at any time.

Join our mailing list Contact us